TY - JOUR
T1 - Midazolam kinetics in women of two age groups
AU - Avram, Michael J.
AU - Fragen, Robert J.
AU - Caldwell, Nancy J.
PY - 1983/10
Y1 - 1983/10
N2 - Midazolam kinetics were determined in 11 younger (22 to 30 yr) and 11 older (50 to 60 yr) women to determine age-related differences in the kinetics of this water-soluble benzodiazepine. Midazolam, 0.2 mg/kg, was injected intravenously over 30 sec for induction of anesthesia that was maintained with 67% nitrous oxide in oxygen and intravenous fentanyl doses. There were no differences between the groups with respect to awakening times or plasma concentrations. Midazolam kinetics were described by a three-compartment open mamillary model. The only differences were small increases in the slow and total volumes of distribution in the older women. The kinetics we determined, including the steady-state volume of distribution of 1.23 l/kg and the elimination clearance of 419 ml/min, are in excellent agreement with those reported by others. Our data suggest that midazolam has advantages over other benzodiazepines, not only because of its water solubility and shorter elimination t 1 2, but also because of little change in its kinetics with age.
AB - Midazolam kinetics were determined in 11 younger (22 to 30 yr) and 11 older (50 to 60 yr) women to determine age-related differences in the kinetics of this water-soluble benzodiazepine. Midazolam, 0.2 mg/kg, was injected intravenously over 30 sec for induction of anesthesia that was maintained with 67% nitrous oxide in oxygen and intravenous fentanyl doses. There were no differences between the groups with respect to awakening times or plasma concentrations. Midazolam kinetics were described by a three-compartment open mamillary model. The only differences were small increases in the slow and total volumes of distribution in the older women. The kinetics we determined, including the steady-state volume of distribution of 1.23 l/kg and the elimination clearance of 419 ml/min, are in excellent agreement with those reported by others. Our data suggest that midazolam has advantages over other benzodiazepines, not only because of its water solubility and shorter elimination t 1 2, but also because of little change in its kinetics with age.
UR - http://www.scopus.com/inward/record.url?scp=0020563546&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020563546&partnerID=8YFLogxK
U2 - 10.1038/clpt.1983.205
DO - 10.1038/clpt.1983.205
M3 - Article
C2 - 6617073
AN - SCOPUS:0020563546
SN - 0009-9236
VL - 34
SP - 505
EP - 508
JO - Clinical pharmacology and therapeutics
JF - Clinical pharmacology and therapeutics
IS - 4
ER -